Interest of in Situ Terlipressin Administration Before the Realisation of Bronchial Biopsy

Inclusion Criteria: * Patients ≥18 years old * Patients scheduled to undergo bronchoscopy, presenting a suspicious radiographic lesion and a lesion proximal tumor pace viewable in white light endoscopy and without pathologic diagnosis * Patient having read and understood the information letter and signed the consent form * Effective contraception in women of childbearing age Exclusion Criteria: * Patients with contraindication to the use of terlipressin: * septic shock , * Hypersensitivity to terlipressin or the excipients or by whom use the product is not recommended: * Recent history (\<3 months) of acute coronary syndrome (including myocardial infarction) or unbalanced coronary insufficiency, or disorders of the ventricular heart rate. * severe uncontrolled hypertension, * cerebrovascular insufficiency and ischemic stroke of recent origin (\<3 months). * severe arterial occlusive lower extremities, * severe chronic renal impairment (GFR \<20 ml / min). * Patients receiving uninterrupted antiplatelet therapy during 5 days before endoscopy (7 days for Clopidogrel Related), including low dose aspirin (≤ 75 mg / day). * Patients receiving anticoagulant therapy: * Unfractionated heparin within 12 hours before endoscopy. * low molecular weight heparin within 24 hours before endoscopy. * Patients with bleeding disorders defined by TP below 70% or TCA ratio patient / control greater than 1.3. * Patients with thrombocytopenia less than 100 g / L. * Subjects misunderstanding of spoken and written French * Person under guardianship or deprived of liberty by judicial or administrative decision (under Article L1121-6 and L1121-8 of Public Health Code * Pregnant or lactating women, premenopausal women without adequate contraception * Patient participating in other drug testing or participating in another drug test in the previous month